Literature DB >> 1768588

Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances. I.

H Trachtman1.   

Abstract

Control of cell size within defined limits is vital for maintenance of normal organ function. This important feature of cell physiology can be disturbed by changes in membrane transport in epithelial cells. In addition, fluctuations in the osmolality of the extracellular fluid, caused by an abnormal plasma concentration of sodium, glucose, or urea can lead to derangements in cell size. Cell volume regulation is especially important in the brain because the brain is confined within a non-compliant vault and cannot tolerate significant perturbations in cell size. Therefore, brain cells have developed a coordinated array of adaptive mechanisms designed to modulate the cytosolic content of osmotically active solutes in response to alterations in the osmolality of the extracellular fluid. This process is controlled by various hormones including arginine vasopressin, insulin, and estrogen, and is subject to changes during development. The bulk of the change in cell content of osmolytes involves inorganic electrolytes. However, excessive variation in the cytosolic ionic strength has deleterious effects on protein structure and enzyme function. Therefore, brain cells have developed the capacity to accumulate or extrude various organic osmolytes in order to adjust the cytosolic osmolality without adversely affecting cell function. These solutes are termed non-perturbing osmolytes and belong to one of three classes of molecules: amino acids, carbohydrates and polyhydric sugar alcohols, or methylamines. Cerebral cells regulate the cytosolic content of organic osmolytes primarily by altering the transmembrane flux of these solutes. There are features of the cell volume regulatory response that are shared by the brain and kidney cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1768588     DOI: 10.1007/bf00857889

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  53 in total

Review 1.  Metabolic coma.

Authors:  C R Kleeman
Journal:  Kidney Int       Date:  1989-12       Impact factor: 10.612

2.  Role of prostaglandins and leukotrienes in volume regulation by Ehrlich ascites tumor cells.

Authors:  I H Lambert; E K Hoffmann; P Christensen
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

3.  Intracellular betaine substitutes for sorbitol in protecting renal medullary cells from hypertonicity.

Authors:  T Moriyama; A Garcia-Perez; A D Olson; M B Burg
Journal:  Am J Physiol       Date:  1991-04

4.  Mechanisms of cell volume regulation by the mouse medullary thick ascending limb of Henle.

Authors:  A M Sun; S N Saltzberg; D Kikeri; S C Hebert
Journal:  Kidney Int       Date:  1990-12       Impact factor: 10.612

5.  Osmoregulation of glycerophosphorylcholine content of mammalian renal cells.

Authors:  T Nakanishi; M B Burg
Journal:  Am J Physiol       Date:  1989-10

6.  Mediation of cell volume regulation by Ca2+ influx through stretch-activated channels.

Authors:  O Christensen
Journal:  Nature       Date:  1987 Nov 5-11       Impact factor: 49.962

7.  Model of renal cell volume regulation without active transport: role of a heteroporous membrane.

Authors:  D J Welling; L W Welling
Journal:  Am J Physiol       Date:  1988-09

8.  Sex differences result in increased morbidity from hyponatremia in female rats.

Authors:  C L Fraser; J Kucharczyk; A I Arieff; C Rollin; P Sarnacki; D Norman
Journal:  Am J Physiol       Date:  1989-04

9.  Expression of Madin-Darby canine kidney cell Na(+)-and Cl(-)-dependent taurine transporter in Xenopus laevis oocytes.

Authors:  S Uchida; H M Kwon; A S Preston; J S Handler
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

10.  Osmoregulation of betaine transport in mammalian renal medullary cells.

Authors:  T Nakanishi; R J Turner; M B Burg
Journal:  Am J Physiol       Date:  1990-04
View more
  8 in total

1.  Effect of hypoxia on the cerebral adaptation to acute hyponatremia in experimental animals.

Authors:  Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2006-10-17       Impact factor: 3.714

2.  Effect of hyperosmotic conditions on the expression of the betaine-GABA-transporter (BGT-1) in cultured mouse astrocytes.

Authors:  Mads Olsen; Alan Sarup; Orla M Larsson; Arne Schousboe
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

3.  Hypoxic cellular deterioration and its prevention by the amino acid taurine in a transplantation model with renal tubular cells (LLC-PK1).

Authors:  P Wingenfeld; T Minor; U Gehrmann; S Strübind; W Isselhard; D Michalk
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995 Jul-Aug       Impact factor: 2.416

Review 4.  Clinical semiology and neuroradiologic correlates of acute hypernatremic osmotic challenge in adults: a literature review.

Authors:  F Y Ismail; A Szóllics; M Szólics; N Nagelkerke; M Ljubisavljevic
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-14       Impact factor: 3.825

5.  The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children.

Authors:  J A Edge; R W Jakes; Y Roy; M Hawkins; D Winter; M E Ford-Adams; N P Murphy; A Bergomi; B Widmer; D B Dunger
Journal:  Diabetologia       Date:  2006-07-18       Impact factor: 10.122

Review 6.  Hypertonic saline: a clinical review.

Authors:  R Tyagi; K Donaldson; C M Loftus; J Jallo
Journal:  Neurosurg Rev       Date:  2007-06-16       Impact factor: 3.042

Review 7.  Renal amino acid transport: cellular and molecular events from clearance studies to frog eggs.

Authors:  R W Chesney; D Jones; I Zelikovic
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

8.  Chloroquine, a novel inhibitor of amino acid transport by rat renal brush border membrane vesicles.

Authors:  R W Chesney; A M Budreau
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.